Cargando…
Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice
BACKGROUND: Thymidine kinase 2 (TK2) catalyses the phosphorylation of deoxythymidine (dThd) and deoxycytidine (dCtd) within mitochondria. TK2 deficiency leads to mtDNA depletion or accumulation of multiple deletions. In patients, TK2 mutations typically manifest as a rapidly progressive myopathy wit...
Autores principales: | Blázquez-Bermejo, Cora, Molina-Granada, David, Vila-Julià, Ferran, Jiménez-Heis, Daniel, Zhou, Xiaoshan, Torres-Torronteras, Javier, Karlsson, Anna, Martí, Ramon, Cámara, Yolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711114/ https://www.ncbi.nlm.nih.gov/pubmed/31351931 http://dx.doi.org/10.1016/j.ebiom.2019.07.042 |
Ejemplares similares
-
Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy
por: Hernandez-Voth, Ana, et al.
Publicado: (2020) -
Therapy Prospects for Mitochondrial DNA Maintenance Disorders
por: Ramón, Javier, et al.
Publicado: (2021) -
Identification and Characterization of New RNASEH1 Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions
por: Carreño-Gago, Lidia, et al.
Publicado: (2019) -
Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides
por: Vila-Julià, Ferran, et al.
Publicado: (2020) -
Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency
por: Lopez-Gomez, Carlos, et al.
Publicado: (2019)